Evidence map›Paper›PMID 42052319›Full record

ArticleFrontiers in ophthalmology2026

Use of preoperative swept-source optical coherence tomography in vitrectomy for advanced diabetic eye disease: a pilot study.

Arshad Mehmood, Altamash Shahriyar Ghazanfar, M A Rehman Siddiqui

Abstract read
In one paragraph

Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arshad Mehmood *Shahzad Eye Hospital, Karachi, Pakistan.
Altamash Shahriyar Ghazanfar *Department of Ophthalmology and Visual Sciences, Aga Khan University Hospital, Karachi, Pakistan.
M A Rehman SiddiquiShahzad Eye Hospital, Karachi, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Swept-source optical coherence tomography (SS-OCT) is an OCT variant with longer wavelengths than other commonly used OCT devices. Our aim was to determine the benefit of pre-operative SS-OCT to detect occult retinal pathologies in patients with advanced diabetic eye disease (ADED). Methods: Fundus photos and SS-OCT were performed pre-operatively in all patients scheduled for vitrectomy for ADED. These were reviewed by two retina specialists. A modified BIO-score based on the Nussenblatt scale of vitreous haze was used to evaluate fundus clarity on fundus photos. Findings on fundus photos were compared with the findings on SS-OCT. Any disagreement between the retina specialists was resolved upon discussion. Results: We included 38 consecutive eyes of 35 patients. Various degrees of cataract was present in 22 eyes. In our sample, 84.2% of cases had a BIO score of 3 or more and 31.6% had a BIO score of 4 or 5. The most common diagnosis on fundus photos was vitreous haemorrhage (n = 23). Tractional retinal detachment (n = 20) was the most common diagnosis on SS-OCT. Only 3 cases had no view on SS-OCT. There was almost perfect (κ = 0.933, 95% CI: 0.887-0.979), substantial (κ = 0.734, 95% CI: 0.632-0.836) and moderate (κ = 0.593, 95% CI: 0.494-0.692) intergrader agreement for fundus photo diagnosis, SS-OCT diagnosis and BIO scores respectively. Conclusion: SS-OCT showed potential as an adjunct to clinical examinations, especially when hazy media opacities did not allow for a clear view of the fundus. However, it is important to recognise that OCT only serves as an adjunct and cannot be used as a definitive argument for assessing surgical feasibility.

Indexed as

diabetes mellitusdiabetic retinopathyimagingretinavitreoretinal surgery

Identifiers

PMID42052319
PMCPMC13111141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.